Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April
Feb 22, 2021
Paris [France], February 22 : Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates,...